Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology

Kamelia Hristova-Panusheva,Charilaos Xenodochidis,Milena Georgieva,Natalia Krasteva
DOI: https://doi.org/10.3390/ph17060677
IF: 4.6
2024-05-25
Pharmaceuticals
Abstract:Nanotechnology has emerged as a transformative force in oncology, facilitating advancements in site-specific cancer therapy and personalized oncomedicine. The development of nanomedicines explicitly targeted to cancer cells represents a pivotal breakthrough, allowing the development of precise interventions. These cancer-cell-targeted nanomedicines operate within the intricate milieu of the tumour microenvironment, further enhancing their therapeutic efficacy. This comprehensive review provides a contemporary perspective on precision cancer medicine and underscores the critical role of nanotechnology in advancing site-specific cancer therapy and personalized oncomedicine. It explores the categorization of nanoparticle types, distinguishing between organic and inorganic variants, and examines their significance in the targeted delivery of anticancer drugs. Current insights into the strategies for developing actively targeted nanomedicines across various cancer types are also provided, thus addressing relevant challenges associated with drug delivery barriers. Promising future directions in personalized cancer nanomedicine approaches are delivered, emphasising the imperative for continued optimization of nanocarriers in precision cancer medicine. The discussion underscores translational research's need to enhance cancer patients' outcomes by refining nanocarrier technologies in nanotechnology-driven, site-specific cancer therapy an.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The paper attempts to address the issue of how to achieve precise drug delivery systems through nanotechnology in oncology to improve the effectiveness of cancer treatment. Specifically, the paper explores the application of nanoparticle-mediated drug delivery systems in precise targeting of cancer treatment, aiming to overcome the limitations of traditional cancer treatment methods (such as surgery, chemotherapy, and radiotherapy), including side effects due to lack of specificity, penetration limitations in solid tumors, and issues with drug solubility and resistance. The paper emphasizes the potential of nanotechnology in enhancing drug stability, solubility, and retention time at tumor sites, and discusses the unique advantages and applications of different types of nanoparticles (such as liposomes, polymer nanoparticles, dendrimers, nanocrystals, nanogels, and quantum dots) in cancer treatment. Additionally, the paper proposes future directions for personalized cancer nanomedicine, highlighting the importance of continuing to optimize nanocarrier technologies to improve treatment outcomes for cancer patients.